Advancing New Standards in Reproductive Health (ANSIRH), Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA.
Ibis Reproductive Health, Oakland, CA, USA.
BMC Womens Health. 2019 Oct 15;19(1):118. doi: 10.1186/s12905-019-0816-0.
Medical abortion (MA) has become an increasingly popular choice for women even where surgical abortion services are available. Pain is often cited by women as one of the worst aspects of the MA experience, yet we know little about women's experience with pain management during the process, particularly in low resource settings. The aim of this study is to better understand women's experiences of pain with MA and strategies for improving quality of care.
This qualitative study was conducted as part of a three-arm randomized, controlled trial in Nepal, Vietnam, and South Africa to investigate the effect of prophylactic pain management on pain during MA through 63 days' gestation. We purposively sampled seven parous and seven nulliparous women with a range of reported maximum pain levels from each country, totaling 42 participants. Thematic content analysis focused on MA pain experiences and management of pain compared to menstruation, labor, and previous abortions.
MA is relatively less painful compared to giving birth and relatively more painful than menstruation, based on four factors: pain intensity, duration, associated symptoms and side effects, and response to pain medications. We identified four types of pain trajectories: minimal overall pain, brief intense pain, intermittent pain, and constant pain. Compared to previous abortion experiences, MA pain was less extreme (but sometimes longer in duration), more private, and less frightening. There were no distinct trends in pain trajectories by treatment group, parity, or country. Methods of coping with pain in MA and menstruation are similar in each respective country context, and use of analgesics was relatively uncommon. The majority of respondents reported that counseling about pain management before the abortion and support during the abortion process helped ease their pain and emotional stress.
Pain management during MA is increasingly essential to ensuring quality abortion care in light of the growing proportion of abortions completed with medication around the world. Incorporating a discussion about pain expectations and pain management strategies into pre-MA counseling and providing access to information and support during the MA process could improve the quality of care and experiences of MA patients.
Australian New Zealand Clinical Trials Registry ACTRN12613000017729 , registered January 8, 2013.
即使在可提供手术性堕胎服务的地方,药物性堕胎(MA)也已成为越来越多女性的首选。疼痛通常被女性认为是 MA 体验中最糟糕的方面之一,但我们对女性在该过程中管理疼痛的体验知之甚少,尤其是在资源匮乏的环境中。本研究旨在更好地了解女性在 MA 过程中疼痛的体验以及改善护理质量的策略。
本定性研究是在尼泊尔、越南和南非进行的一项三臂随机对照试验的一部分,旨在调查通过 63 天妊娠预防性疼痛管理对 MA 过程中疼痛的影响。我们从每个国家有一系列报告的最大疼痛水平的 7 名经产妇和 7 名未产妇中进行了有针对性的抽样,共计 42 名参与者。主题内容分析重点关注 MA 疼痛体验以及与月经、分娩和先前堕胎的疼痛管理。
基于四个因素,与分娩相比,MA 相对较不痛,与月经相比,MA 相对较痛:疼痛强度、持续时间、相关症状和副作用以及对疼痛药物的反应。我们确定了四种疼痛轨迹类型:总体疼痛轻微、短暂剧烈疼痛、间歇性疼痛和持续疼痛。与先前的堕胎经历相比,MA 疼痛的程度不那么剧烈(但有时持续时间更长),更私密,也不那么可怕。治疗组、经产状况或国家之间的疼痛轨迹没有明显的趋势。在每个国家的背景下,MA 和月经期间的疼痛应对方法相似,镇痛药的使用相对较少。大多数受访者报告说,在堕胎前进行疼痛管理咨询以及在堕胎过程中提供支持有助于减轻她们的疼痛和情绪压力。
鉴于世界各地越来越多地使用药物完成堕胎,因此,在确保高质量堕胎护理的背景下,MA 期间的疼痛管理变得越来越重要。在 MA 前咨询中纳入关于疼痛预期和疼痛管理策略的讨论,并在 MA 过程中提供信息和支持,可提高 MA 患者的护理质量和体验。
澳大利亚和新西兰临床试验注册中心 ACTRN12613000017729,注册于 2013 年 1 月 8 日。